Zydus Cadila gets USFDA tentative nod for epilepsy treatment drug

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, Cadila Healthcare said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gjCOuR
via IFTTT